Tazarotene (Compound)

Synonyms:tazarotene, 118292-40-3, Tazorac, Zorac, Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate, Avage, AGN-190168, Fabior, AGN 190168, Tazarotene (Avage), UNII-81BDR9Y8PS, C21H21NO2S, 81BDR9Y8PS, CHEMBL1657, ethyl 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylate, CHEBI:32184, ethyl 6-[2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)ethynyl]pyridine-3-carboxylate, NCGC00167525-01, ethyl 6-[(4,4-dimethyl-3,4-dihydro-2H-thiochromen-6-yl)ethynyl]nicotinate, DSSTox_CID_26691, DSSTox_RID_81825, DSSTox_GSID_46691, tazaroteno, tazarotenum, Suretin, Tazoral, Zora, 6-(4,4-Dimethyl-thiochroman-6-ylethynyl)-nicotinic acid ethyl ester, Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate;6-(4,4-dimethyl-thiochroman-6-ylethynyl)-nicotinic acid ethyl ester, Tazorac (TN), Avage (TN), CAS-118292-40-3, Acnitaz, ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate, ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)-ethynyl)nicotinate, Ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)-ethynyl]nicotinate, Tazarotene (JAN/USAN/INN), Tazarotene [USAN:INN:BAN], Zorac|||Tazorac, Tazarotene,(S), Tazarotene- Bio-X, Fabior (TN), 3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester, SCHEMBL3134, MLS003915630, BIDD:GT0293, GTPL6952, DTXSID5046691, HMS3655K05, HMS3747C19, HMS3747E19, ACT06773, AMY31169, BCP22966, ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl] nicotinate, ZINC1542199, Tox21 112522, Tox21_112522, AC-755, BDBM50265951, MFCD00867628, s1569, AKOS015902872, Tox21_112522_1, BS-1012, CCG-268046, CS-1029, DB00799, NCGC00167525-02, NCGC00167525-03, 6-[(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic acid ethyl ester, BT164442, HY-15388, SMR002096194, BCP0726000163, AB0012671, DB-014992, FT-0652578, SW220026-1, T3108, AGN190168, AGN-190168, D01132, 15146-EP2275420A1, 15146-EP2295055A2, 15146-EP2295416A2, 15146-EP2298748A2, 15146-EP2298764A1, 15146-EP2298765A1, 15146-EP2298768A1, 15146-EP2305642A2, 15146-EP2308861A1, 15146-EP2311453A1, 15146-EP2311808A1, 15146-EP2311829A1, 15146-EP2314590A1, 15146-EP2316832A1, 15146-EP2316833A1, AB01274801-01, AB01274801_02, 292T403

Pubchem:PUBCHEM:5381

Id:5381

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Tazarotene's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Tazarotene.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Tazarotene.

Results found

Linked to

	Label	Description
	BRD-K76841105-001-04-7 Substance (Entity type)	A Substance
	tazarotene (30a236ab-55ef-4337-840e-f3ebae28dd8e) Collection (Entity type)	Metadatata for tazarotene
	DCSTRUCT ID 02571 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02571; PubChem_CID:5381, FILE=drugcentral_drug_02571.json)
	tazarotene negatively regulates CD40 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tazarotene bioactivity Retinoic acid receptor beta Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	tazarotene positively regulates RBM47 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tazarotene negatively regulates MT1E Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tazarotene negatively regulates TNNT1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tazarotene in similarity relationship with Palovarotene Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tazarotene positively regulates DNAJC12 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS